Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors

Detalles Bibliográficos
Autor principal: Neuroscience, Computational Intelligence and
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807300/
https://www.ncbi.nlm.nih.gov/pubmed/36601276
http://dx.doi.org/10.1155/2022/9854614
_version_ 1784862690913550336
author Neuroscience, Computational Intelligence and
author_facet Neuroscience, Computational Intelligence and
author_sort Neuroscience, Computational Intelligence and
collection PubMed
description
format Online
Article
Text
id pubmed-9807300
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-98073002023-01-03 Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors Neuroscience, Computational Intelligence and Comput Intell Neurosci Retraction Hindawi 2022-12-26 /pmc/articles/PMC9807300/ /pubmed/36601276 http://dx.doi.org/10.1155/2022/9854614 Text en Copyright © 2022 Computational Intelligence and Neuroscience. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Neuroscience, Computational Intelligence and
Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title_full Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title_fullStr Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title_full_unstemmed Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title_short Retracted: Effects of CIK Cell Therapy Combined with Camrelizumab on the Quality of Life in Patients with Nasopharyngeal Carcinoma and Analysis of Prognostic Factors
title_sort retracted: effects of cik cell therapy combined with camrelizumab on the quality of life in patients with nasopharyngeal carcinoma and analysis of prognostic factors
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807300/
https://www.ncbi.nlm.nih.gov/pubmed/36601276
http://dx.doi.org/10.1155/2022/9854614
work_keys_str_mv AT neurosciencecomputationalintelligenceand retractedeffectsofcikcelltherapycombinedwithcamrelizumabonthequalityoflifeinpatientswithnasopharyngealcarcinomaandanalysisofprognosticfactors

Ejemplares similares